Tech Company Financing Transactions

Univercells SA Funding Round

On 7/17/2018, Univercells SA landed $18.8 million in Series B funding from Global Health Investment Fund, ClubDeal and Inventures Group.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

Rue Auguste Piccard 48
Gosselies, 6041
Belgium

Phone

+32 (0)2 318 83 48

Website

www.univercells.com

Email Address

[email protected]

Overview

Access to health is today unequal around the world. At Univercells, we are on a mission to make biologics available and affordable. We believe this can only happen by changing the rules, especially for biomanufacturing. And by bringing out the best of technology innovations.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Hughes Bultot

        

Chief Financial Officer

Vincent Vanderborght

        

Chief Operating Officer

Christian Borgniet

        

Chief Technical Officer

José Castillo

        

VP - Engineering

Pierre Kayenbergh

        

VP - General Counsel

David Shofi

        

VP - Human Resources

David Louvet

        

Browse more venture capital transactions:

Prev: 7/17/2018: Verge Genomics venture capital transaction
Next: 7/17/2018: Revel Systems venture capital transaction

Share this article

News on VC Transactions

Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary